Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David Ganderton is active.

Publication


Featured researches published by David Ganderton.


Archive | 2001

Stable pharmaceutical solution formulations for pressurised metered dose inhalers

David Lewis; David Ganderton; Brian Meakin; Gaetano Brambilla; Alessandra Ferraris


Archive | 1999

Pressurised metered dose inhalers (MDI)

David Lewis; David Ganderton; Brian Meakin; Paolo Ventura; Gaetano Brambilla; Raffaella Garzia


Archive | 2004

Dry power inhaler devices and dry power formulations for enhancing dosing efficiency

John Nicholas Staniforth; David Alexander Vodden Morton; Michael Tobyn; Stephen William Eason; Quentin Harmer; David Ganderton


Archive | 1999

PHARMACEUTICAL AEROSOL COMPOSITION CONTAINING HFA 227 AND HFA 134a

David Lewis; David Ganderton; Brian Meakin; Paolo Ventura; Gaetano Brambilla; Raffaella Garzia


Archive | 2001

Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease

David Lewis; David Ganderton; Brian Meakin; Gaetano Brambilla; Alessandra Ferraris


Archive | 2004

Mucoactive agents for treating a pulmonary disease

David Alexander Vodden Morton; David Ganderton; John Nicholas Staniforth; Yorick Kamlag


Archive | 2003

Composition, device, and method for treating sexual dysfunction via inhalation

John Nicholas Staniforth; David Alexander Vodden Morton; Michael Tobyn; Stephen William Eason; Quentin Harmer; David Ganderton


Archive | 2004

Devices and pharmaceutical compositions for enhancing dosing efficiency

John Nicholas Staniforth; David Alexander Vodden Morton; Michael Tobyn; Stephen William Eason; Quentin Harmer; David Ganderton


Archive | 2003

Formoterol superfine formulation

Rebecca Jaine Davies; David Ganderton; David Lewis; Brian Meakin; Tanya Church; Gaetano Brambilla; Alessandra Ferraris


Archive | 2003

Pressurised metered dose inhalers containing solutions of beta-2 agonists

Rebecca Jaine Davies; David Ganderton; David Lewis; Brian Meakin; Tanya Church; Gaetano Brambilla; Alessandra Ferraris

Collaboration


Dive into the David Ganderton's collaboration.

Top Co-Authors

Avatar

David Lewis

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors

Avatar

Gaetano Brambilla

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Brian Meakin

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors

Avatar

Paolo Ventura

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors

Avatar

Raffaella Garzia

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Tanya Church

Chiesi Farmaceutici S.p.A.

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge